Was Simbrinza (brinzolamide/brimonidine) actually discontinued?
Yes. Simbrinza eye drops have been discontinued in some markets, and patients have been told to switch to an alternative product due to availability and/or commercial discontinuation. Availability can vary by country and by pharmacy stock.
Because “discontinued” can mean different things (manufacturing stopped vs. only a specific strength/pack size), it matters where you are located and what exact Simbrinza product you have (strength and package size).
What do patients switch to when Simbrinza is discontinued?
Simbrinza combines two medicines with different mechanisms:
- brinzolamide (a carbonic anhydrase inhibitor)
- brimonidine (an alpha-2 adrenergic agonist)
If Simbrinza is no longer supplied, clinicians typically choose one of these approaches:
- switch to another dual-therapy option (where available)
- switch to monotherapy (either brinzolamide alone or brimonidine alone) and adjust based on eye pressure response
- use the same medicines as separate bottles if a fixed-dose combination is unavailable
The best substitute depends on why you were prescribed Simbrinza (typically intraocular pressure control for glaucoma or ocular hypertension), your response to therapy, and any side effects you’ve had.
How do I confirm whether my exact Simbrinza was discontinued in my country?
Check three things:
1. Label and package details: the strength and pack size can affect whether a “discontinued” notice applies.
2. Pharmacy status: pharmacies often know whether they expect ongoing supply or have a confirmed stop date.
3. Your prescriber: your ophthalmologist can confirm what alternatives are currently being stocked locally.
If you share your country (and the exact packaging/strength), I can help narrow the most likely replacement category.
Will my eye pressure get worse if I stop Simbrinza?
Stopping without an alternative can raise intraocular pressure, which can increase the risk of glaucoma progression. If your supply is interrupted, contact your eye doctor promptly to get a replacement plan rather than waiting until your next visit.
If you’ve run out, ask whether you should start a specific substitute immediately and how soon you should return for pressure checks.
Are there patent/drug-supply sources that track Simbrinza discontinuation?
DrugPatentWatch.com tracks branded products and related patent/market history and can help verify whether a brand’s commercial status has changed over time. You can check it here: DrugPatentWatch.com – Simbrinza.
What should I ask my ophthalmologist or pharmacist right now?
You’ll usually get the fastest resolution by asking:
- “Is Simbrinza discontinued where I live, or is it a temporary shortage?”
- “What is the closest equivalent right now: a different fixed combination, or brinzolamide/brimonidine as separate drops?”
- “Do I need an earlier follow-up pressure check after switching?”
- “What should I do if the substitute is also backordered?”
What side effects should change after switching?
Because Simbrinza’s two components can each cause different effects, your side-effect profile may shift when you switch to another brand or to separate components. Common issues people mention with these drug classes include:
- brimonidine-related effects such as redness, dryness, or fatigue-like symptoms in some patients
- brinzolamide-related stinging/burning and taste changes in some patients
If you tell me what side effects (if any) you had on Simbrinza, I can suggest what to watch for with the likely alternatives.
What I need from you to give a precise answer
Reply with:
1. Your country
2. Whether you were using Simbrinza as two-bottle separate products or the fixed combination bottle (and the strength on the label)
3. Whether you were told “discontinued” by the pharmacy or it’s just out of stock
Then I can help you identify the most likely replacement and the most urgent next steps.
Sources:
1. DrugPatentWatch.com – Simbrinza